Understanding lactate in the development of Hepatitis B virus-related hepatocellular carcinoma
- PMID: 39010155
- PMCID: PMC11247867
- DOI: 10.1186/s13027-024-00593-4
Understanding lactate in the development of Hepatitis B virus-related hepatocellular carcinoma
Abstract
Hepatitis B Virus (HBV) is a hepatotropic virus that can establish a persistent and chronic infection in humans. Chronic hepatitis B (CHB) infection is associated with an increased risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma (HCC). Lactate level, as the end product of glycolysis, plays a substantial role in metabolism beyond energy production. Emerging studies indicate that lactate is linked to patient mortality rates, and HBV increases overall glucose consumption and lactate production in hepatocytes. Excessive lactate plays a role in regulating the tumor microenvironment (TME), immune cell function, autophagy, and epigenetic reprogramming. The purpose of this review is to gather and summarize the existing knowledge of the lactate's functions in the dysregulation of the immune system, which can play a crucial role in the development of HBV-related HCC. Therefore, it is reasonable to hypothesize that lactate with intriguing functions can be considered an immunomodulatory metabolite in immunotherapy.
Keywords: Hepatitis B Virus; Hepatocellular Carcinoma; Immune System; Lactate.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.Front Immunol. 2020 May 28;11:1037. doi: 10.3389/fimmu.2020.01037. eCollection 2020. Front Immunol. 2020. PMID: 32547550 Free PMC article. Review.
-
Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol. 2000 May;15 Suppl:E25-30. doi: 10.1046/j.1440-1746.2000.02097.x. J Gastroenterol Hepatol. 2000. PMID: 10921378
-
The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma.Immunology. 2024 Apr;171(4):445-463. doi: 10.1111/imm.13738. Epub 2023 Dec 14. Immunology. 2024. PMID: 38093705 Review.
-
Hepatitis B Virus-Associated Hepatocellular Carcinoma.Viruses. 2022 May 7;14(5):986. doi: 10.3390/v14050986. Viruses. 2022. PMID: 35632728 Free PMC article. Review.
-
Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.Sci Rep. 2024 May 14;14(1):10996. doi: 10.1038/s41598-024-61820-x. Sci Rep. 2024. PMID: 38744926 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources